{"id":"https://openalex.org/W6995628007","doi":null,"title":"Part A: Monoclonal antibody formulations: challenges and developments/ Part B: Characterization of an IgG fab fragment in non-aqueous solvent: Isopropyl Alcohol (IPA)","display_name":"Part A: Monoclonal antibody formulations: challenges and developments/ Part B: Characterization of an IgG fab fragment in non-aqueous solvent: Isopropyl Alcohol (IPA)","alternate_titles":[],"publication_year":2022,"publication_date":"2022-08-03","ids":{"openalex":"https://openalex.org/W6995628007"},"language":"en","primary_location":{"id":"pmh:oai:eprints.nottingham.ac.uk:67069","doi":null,"is_oa":false,"landing_page_url":"http://eprints.nottingham.ac.uk/67069/1/KeshaShah_MResDissertation2021.pdf","pdf_url":"http://eprints.nottingham.ac.uk/67069/1/KeshaShah_MResDissertation2021.pdf","source":{"id":"https://openalex.org/S4306402014","display_name":"Nottingham ePrints (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Thesis (University of Nottingham only)"},"parent_works":[],"lineage":["https://openalex.org/W6995628007"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://repository.nottingham.ac.uk/bitstreams/64f7413d-d5a2-4c84-85de-4d756ba072dc/download","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Shah, Kesha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Shah, Kesha","raw_affiliation_strings":["School of Biosciences, Sutton Bonington Campus, University of Nottingham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Biosciences, Sutton Bonington Campus, University of Nottingham","institution_ids":["https://openalex.org/I142263535"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I142263535"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.8720999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.8720999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.12460000067949295,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoclonal-antibody-formulations","display_name":"monoclonal antibody formulations","score":0.972000002861023},{"id":"https://openalex.org/keywords/isopropanol","display_name":"isopropanol","score":0.9639999866485596},{"id":"https://openalex.org/keywords/nonaqueous-solvents","display_name":"non-aqueous solvents","score":0.9700000286102295},{"id":"https://openalex.org/keywords/protein-stability","display_name":"protein stability","score":0.7620000243186951},{"id":"https://openalex.org/keywords/protein-aggregation","display_name":"protein aggregation","score":0.8050000071525574},{"id":"https://openalex.org/keywords/high-concentration-formulations","display_name":"high-concentration formulations","score":0.7609999775886536},{"id":"https://openalex.org/keywords/viscosity","display_name":"viscosity","score":0.7210000157356262},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.7879999876022339},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.9990000128746033},{"id":"https://openalex.org/keywords/protein-protein-interaction","display_name":"protein-protein interaction","score":0.6349999904632568},{"id":"https://openalex.org/keywords/biopharmaceutical-development","display_name":"biopharmaceutical development","score":0.4819999933242798}],"concepts":[{"id":"https://openalex.org/C2775850501","wikidata":"https://www.wikidata.org/wiki/Q16392","display_name":"Isopropyl alcohol","level":2,"score":0.5637999773025513},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5590999722480774},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5530999898910522},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.46790000796318054},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.4009999930858612},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.30219998955726624},{"id":"https://openalex.org/C127172972","wikidata":"https://www.wikidata.org/wiki/Q128709","display_name":"Viscosity","level":2,"score":0.29840001463890076},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.29739999771118164},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2969000041484833},{"id":"https://openalex.org/C2778636629","wikidata":"https://www.wikidata.org/wiki/Q422649","display_name":"Biopolymer","level":3,"score":0.2757999897003174},{"id":"https://openalex.org/C54689828","wikidata":"https://www.wikidata.org/wiki/Q2029259","display_name":"Ultracentrifuge","level":2,"score":0.2702000141143799},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.27000001072883606},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2667999863624573},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.2662999927997589},{"id":"https://openalex.org/C2776235265","wikidata":"https://www.wikidata.org/wiki/Q18392052","display_name":"Fragment (logic)","level":2,"score":0.25850000977516174},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.25760000944137573},{"id":"https://openalex.org/C2781066024","wikidata":"https://www.wikidata.org/wiki/Q156","display_name":"Alcohol","level":2,"score":0.25519999861717224}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:eprints.nottingham.ac.uk:67069","doi":null,"is_oa":false,"landing_page_url":"http://eprints.nottingham.ac.uk/67069/1/KeshaShah_MResDissertation2021.pdf","pdf_url":"http://eprints.nottingham.ac.uk/67069/1/KeshaShah_MResDissertation2021.pdf","source":{"id":"https://openalex.org/S4306402014","display_name":"Nottingham ePrints (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Thesis (University of Nottingham only)"},{"id":"pmh:oai:repository.nottingham.ac.uk:123456789/59546","doi":null,"is_oa":true,"landing_page_url":"https://repository.nottingham.ac.uk/handle/123456789/59546","pdf_url":"https://repository.nottingham.ac.uk/bitstreams/64f7413d-d5a2-4c84-85de-4d756ba072dc/download","source":{"id":"https://openalex.org/S4306402014","display_name":"Nottingham ePrints (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"ethesis"}],"best_oa_location":{"id":"pmh:oai:repository.nottingham.ac.uk:123456789/59546","doi":null,"is_oa":true,"landing_page_url":"https://repository.nottingham.ac.uk/handle/123456789/59546","pdf_url":"https://repository.nottingham.ac.uk/bitstreams/64f7413d-d5a2-4c84-85de-4d756ba072dc/download","source":{"id":"https://openalex.org/S4306402014","display_name":"Nottingham ePrints (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"ethesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.428600013256073}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W6995628007.pdf","grobid_xml":"https://content.openalex.org/works/W6995628007.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W788465070","https://openalex.org/W1560895248","https://openalex.org/W1576271719","https://openalex.org/W2005697596","https://openalex.org/W2010614425","https://openalex.org/W2028262396","https://openalex.org/W2030185855","https://openalex.org/W2033785641","https://openalex.org/W2071226935","https://openalex.org/W2073948759","https://openalex.org/W2101002332","https://openalex.org/W2105615908","https://openalex.org/W2144063308","https://openalex.org/W2165752272","https://openalex.org/W2176761023","https://openalex.org/W2229692518","https://openalex.org/W2415525327","https://openalex.org/W2475096707","https://openalex.org/W2610034922","https://openalex.org/W2730013470","https://openalex.org/W2765546463","https://openalex.org/W2768717631","https://openalex.org/W2769896382","https://openalex.org/W2792454824","https://openalex.org/W2802215780","https://openalex.org/W2883052264","https://openalex.org/W2970803602","https://openalex.org/W2995764973","https://openalex.org/W3046480764","https://openalex.org/W3083621646","https://openalex.org/W3085831021","https://openalex.org/W3096590756","https://openalex.org/W3107418741","https://openalex.org/W3121604222","https://openalex.org/W3131091842","https://openalex.org/W3142072058"],"related_works":["https://openalex.org/W2045936583","https://openalex.org/W4414872113","https://openalex.org/W3122182167","https://openalex.org/W3093558692","https://openalex.org/W7127975831","https://openalex.org/W7166717985","https://openalex.org/W2756823679","https://openalex.org/W2725756931","https://openalex.org/W1601489911","https://openalex.org/W4309089099"],"abstract_inverted_index":{"Part":[0,127],"A:":[1],"Currently":[2],"there":[3],"are":[4,78],"about":[5],"100":[6],"antibody":[7,37,153],"formulations":[8,31,73,211],"available":[9],"for":[10,108,198,208],"the":[11,27,75,89,132,137,149,156,168,176,190],"treatment":[12],"of":[13,29,43,60,68,70,85,131,151,212],"disease,":[14],"ranging":[15],"from":[16],"migraine":[17],"prevention,":[18],"multiple":[19],"sclerosis":[20],"and":[21,32,45,48,58,62,65,105,120,125,158,166,185,193,200],"leukaemia.":[22],"This":[23,81],"project":[24],"will":[25,54,83,100],"review":[26,53,82],"development":[28],"such":[30,111],"how":[33,66],"they":[34],"relate":[35],"to":[36,50,88,135,164,187,203],"subclass":[38],"structure,":[39],"stability,":[40],"storage,":[41],"prevention":[42],"aggregation":[44,194],"administration,":[46],"costs":[47],"safety":[49],"patients.":[51],"The":[52,129,178],"include":[55],"comparative":[56],"advantages":[57],"challenges":[59,67],"intravenous":[61],"subcutaneous":[63],"administration":[64],"delivery":[69],"high":[71],"concentration":[72,210],"(including":[74],"viscosity":[76],"problem)":[77],"dealt":[79],"with.":[80],"be":[84,204],"great":[86],"value":[87],"newly":[90],"reforming":[91],"NCMH":[92],"Business":[93],"Centre":[94],"based":[95],"at":[96],"Sutton":[97],"Bonington":[98],"which":[99],"act":[101],"as":[102,112,175],"an":[103,152],"advisory":[104],"scientific":[106],"Facility":[107],"Biopharma":[109],"companies":[110],"Astra":[113],"Zeneca,":[114],"Arecor,":[115],"Glaxo":[116],"Smith":[117],"Kline,":[118],"Sanofi":[119],"specialising":[121],"in":[122,140],"biopolymer":[123],"therapeutics":[124],"vaccines.":[126],"B:":[128],"aim":[130],"study":[133],"was":[134],"understand":[136,167,189],"protein-protein":[138,169],"interactions":[139,170],"a":[141],"non-aqueous":[142],"solvents":[143],"allow":[144],"higher":[145,209],"concentration,":[146],"focusing":[147],"on":[148],"stability":[150],"fragment,":[154],"using":[155],"ultracentrifuge":[157],"dynamic":[159],"light":[160],"scattering":[161],"with":[162,171,183],"software":[163],"analyse":[165],"Iso-propyl":[172],"alcohol":[173],"(IPA)":[174],"solvent.":[177],"comparison":[179],"is":[180],"done":[181],"between":[182],"buffer":[184],"IPA":[186,199],"better":[188],"characterization.":[191],"Instabilities":[192],"were":[195],"also":[196],"observed":[197],"showed":[201],"it":[202],"non":[205],"\u2013":[206],"suitable":[207],"antibodies.":[213]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W6995628007","counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2025-10-10T00:00:00"}
